Heat-stress cognate 70 (Hsc70) is a host factor that helps hepatitis C virus (HCV) to complete its life cycle in infected hepatocytes. Using Hsc70 as a target for HCV inhibition, a series of novel N-substituted benzyl matrinic/sophoridinic acid derivatives was synthesized and evaluated for their anti-HCV activity in vitro. Among these analogues, compound 7c possessing N-p-methylbenzyl afforded an appealing ability to inhibit HCV replication with SI value over 53. Furthermore, it showed a good oral pharmacokinetic profile with area-under-curve (AUC) of 13.4 mM?h, and a considerably good safety in oral administration in mice (LD50.1000 mg/kg). As 7c suppresses HCV replication via an action mode distinctly different from that of the marketed a...
[[abstract]]Starting from the initial lead 4-phenylthiazole 18, a modest HCV inhibitor (EC50 = 9440 ...
[[abstract]]A medicinal chemistry program based on the small-molecule HCV NS5A inhibitor daclatasvir...
We have previously identified the pyrazolobenzothiazine scaffold as a promising chemotype against he...
Abstract Background 12N-benzyl matrinic acid analogues had been identified to be a novel scaffold of...
Our study describes the discovery of a series of highly potent hepatitis C virus (HCV) NS5A inhibito...
AbstractChronic hepatitis C virus (HCV) infection has become a major public health burden worldwide....
AbstractA series of novel amino-substituted N-aryl benzamide analogs were synthesized and evaluated ...
Here we report the discovery of a series of potent hepatitis C virus (HCV) NS5A inhibitors based on ...
International audienceAminoquinolines and piperazines, linked or not, have been used successfully to...
Hepatitis C is a global health problem that affects approximately 120–180 million people. This viral...
Novel amidinourea derivatives have been synthesised and evaluated for their antiviral activity again...
Tylophorine analogs have been shown to exhibit diverse activities against cancer, inflammation, arth...
The discovery of a novel class of HCV inhibitors is described. The new amidinourea compounds were de...
Novel amidinourea derivatives have been synthesised and evaluated for their antiviral activity again...
Aminoquinolines and piperazines, linked or not, have been used successfully to treat malaria, and so...
[[abstract]]Starting from the initial lead 4-phenylthiazole 18, a modest HCV inhibitor (EC50 = 9440 ...
[[abstract]]A medicinal chemistry program based on the small-molecule HCV NS5A inhibitor daclatasvir...
We have previously identified the pyrazolobenzothiazine scaffold as a promising chemotype against he...
Abstract Background 12N-benzyl matrinic acid analogues had been identified to be a novel scaffold of...
Our study describes the discovery of a series of highly potent hepatitis C virus (HCV) NS5A inhibito...
AbstractChronic hepatitis C virus (HCV) infection has become a major public health burden worldwide....
AbstractA series of novel amino-substituted N-aryl benzamide analogs were synthesized and evaluated ...
Here we report the discovery of a series of potent hepatitis C virus (HCV) NS5A inhibitors based on ...
International audienceAminoquinolines and piperazines, linked or not, have been used successfully to...
Hepatitis C is a global health problem that affects approximately 120–180 million people. This viral...
Novel amidinourea derivatives have been synthesised and evaluated for their antiviral activity again...
Tylophorine analogs have been shown to exhibit diverse activities against cancer, inflammation, arth...
The discovery of a novel class of HCV inhibitors is described. The new amidinourea compounds were de...
Novel amidinourea derivatives have been synthesised and evaluated for their antiviral activity again...
Aminoquinolines and piperazines, linked or not, have been used successfully to treat malaria, and so...
[[abstract]]Starting from the initial lead 4-phenylthiazole 18, a modest HCV inhibitor (EC50 = 9440 ...
[[abstract]]A medicinal chemistry program based on the small-molecule HCV NS5A inhibitor daclatasvir...
We have previously identified the pyrazolobenzothiazine scaffold as a promising chemotype against he...